The role of the scaffolding protein PTPIP51 in signal transduction in Her2 amplified breast cancer cells
- Alternative title
-
Die Rolle des Gerüstproteins PTPIP51 in der Signaltransduktion von Her2 amplifizierten Brustkrebszellen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Gießen, Justus-Liebig-Universität, Dissertation, 2021
- Keyword
-
Breast--Cancer
Cells
Transduction
- Event
-
Veröffentlichung
- (where)
-
Gießen
- (who)
-
Universitätsbibliothek
- (when)
-
2021
- Creator
- URN
-
urn:nbn:de:hebis:26-opus-160889
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:42 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dietel, Eric
- Universitätsbibliothek
Time of origin
- 2021
Other Objects (12)
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
EGFR Expression in HER2-Driven Breast Cancer Cells
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Therapy landscape in patients with metastatic her2-positive breast cancer: Data from the praegnant real-world breast cancer registry
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Mathematical modeling of drug-induced receptor internalization in the HER2-positive SKBR3 breast cancer cell-line
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
EGFR Expression in HER2-Driven Breast Cancer Cells
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Therapy landscape in patients with metastatic her2-positive breast cancer: Data from the praegnant real-world breast cancer registry
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Mathematical modeling of drug-induced receptor internalization in the HER2-positive SKBR3 breast cancer cell-line
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
EGFR Expression in HER2-Driven Breast Cancer Cells
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Therapy landscape in patients with metastatic her2-positive breast cancer: Data from the praegnant real-world breast cancer registry
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Mathematical modeling of drug-induced receptor internalization in the HER2-positive SKBR3 breast cancer cell-line